BioAtla, Inc. (BCAB) vs Cullinan Therapeutics, Inc. (CGEM)
Detailed comparison between BioAtla, Inc., Cullinan Therapeutics, Inc..Total Return (%)
BioAtla, Inc. (BCAB)Cullinan Therapeutics, Inc. (CGEM)
Which stock do you think will perform better?
BioAtla, Inc.
BCAB
Cullinan Therapeutics, Inc.
CGEM
| Metric | BioAtla, Inc. (BCAB) | Cullinan Therapeutics, Inc. (CGEM) |
|---|---|---|
| Current Price | $1.17 | $9.06 |
| Change | 0.01 (0.87%) | 0.34 (3.96%) |
| Market Cap | $0.07B | $0.54B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -0.80 | -2.79 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $1.90 | $13.78 |
| 52-Week Low | $0.24 | $5.68 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.15 | $-3.32 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| BCAB | 78.35% | 134.47% | -25.48% | -96.23% | -96.23% | -96.23% |
| CGEM | 11.64% | -13.75% | -27.71% | -69.69% | -69.69% | -69.69% |